Table 4.
Cox proportional hazard analysis for all-cause mortality in lung cancer patients
| Univariate | Model 1a) | Model 2b) | Model 3c) | |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|||||
| HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
| No AKI | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | ||||
|
| ||||||||
| AKI stage 1 | 1.32 (1.179–1.476) | < 0.001 | 1.19 (1.058–1.330) | 0.004 | 1.18 (1.047–1.322) | 0.006 | 1.15 (1.022–1.292) | 0.020 |
|
| ||||||||
| AKI stage 2, 3 | 1.88 (1.304–2.715) | < 0.001 | 1.78 (1.230–2.567) | 0.002 | 1.76 (1.217–2.551) | 0.003 | 1.73 (1.194–2.505) | 0.004 |
AKI, acute kidney injury; CI, confidence interval; HR, hazard ratio.
a)
Model 1: age, sex adjusted,
b)
Model 2: model 1+BMI, smoking, initial eGFR, anemia, hyponatremia adjusted,
c)
Model 3: model 2+pathologic subtype adjusted.